Market Insights Health OTC Pharmaceuticals

Skin Treatment - North America

North America

In North America, the Skin Treatment market market generates a revenue of US$4.88bn in 2024.
It is projected to experience a steady annual growth rate of 4.70% (CAGR 2024-2029).
Among all countries worldwide, the in the United States leads in terms of revenue, with US$4,184.00m generated in 2024.
When considering the population size, the per person revenue in 2024 amounts to US$9.55.
North America's skin treatment market is witnessing a surge in demand for natural and organic products.

Key regions: Australia, Brazil, Canada, China, Germany

Market

Region

Region comparison

Currency

Analyst Opinion

The Skin Treatment market in North America is experiencing significant growth and development.

Customer preferences: Customers in North America are increasingly prioritizing skincare and investing in products and treatments that enhance their skin health and appearance. The desire for youthful and radiant skin has driven the demand for skin treatments across the region. Additionally, there is a growing awareness among consumers about the importance of skincare as a part of overall wellness. This has led to an increased willingness to spend on high-quality skin treatment products and services.

Trends in the market: One of the key trends in the North American skin treatment market is the rising popularity of natural and organic skincare products. Consumers are becoming more conscious about the ingredients used in their skincare products and are seeking out natural and organic alternatives. This trend is driven by the belief that natural products are safer and more beneficial for the skin. As a result, there has been a surge in demand for natural and organic skincare brands and products.Another trend in the market is the growing popularity of non-invasive skin treatments. Customers are increasingly opting for non-surgical procedures such as chemical peels, microdermabrasion, and laser treatments. These treatments offer effective results without the need for surgery or extensive downtime, making them more appealing to a wider range of customers. The convenience and minimal risk associated with non-invasive treatments have contributed to their popularity in the North American market.

Local special circumstances: The North American market is highly competitive, with a wide range of skincare brands and treatment providers. This has led to a focus on innovation and differentiation among market players. Companies are constantly introducing new products and treatments to cater to the evolving needs and preferences of customers. The market is also characterized by a strong presence of both established brands and emerging players, creating a dynamic and diverse landscape.

Underlying macroeconomic factors: The growth of the skin treatment market in North America can be attributed to several underlying macroeconomic factors. Firstly, the region has a high disposable income, allowing customers to spend more on skincare products and treatments. Additionally, the influence of social media and celebrity culture has played a significant role in driving the demand for skin treatments. Consumers are increasingly influenced by the beauty standards portrayed on social media platforms and are willing to invest in treatments that help them achieve similar results.Furthermore, the aging population in North America has contributed to the growth of the skin treatment market. As individuals age, they become more concerned about the signs of aging and are willing to invest in treatments that help them maintain a youthful appearance. The increasing focus on wellness and self-care has also contributed to the growth of the market, as customers view skin treatments as a way to take care of their overall well-being.In conclusion, the Skin Treatment market in North America is experiencing significant growth and development. Customer preferences for natural and non-invasive treatments, along with the presence of a competitive market and underlying macroeconomic factors, are driving this growth.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.